Merit Medical Systems Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
9.0%projected annual EPS growth
Analyst Coverage
11analysts covering
FY Revenue (est.)
$1.6Bnext fiscal year
FY EPS (est.)
$4.30next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release & Investor Call | 29 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Organic Constant Currency Revenue Growth Quarterly370.0%Target: 5% to 7%
Non-GAAP Operating Margin Quarterly1,970.0%Target: 20% to 22% (CGI Program Target)
Cumulative Free Cash Flow Generation Quarterly2,470.0%Target: >$400 million (cumulative FY 2024-2026)
Watch Items
- Integration of View Point Medical AcquisitionTrigger: Revenue contribution below $2M-$4M in FY 2026 or failure to reach $14M-$16M in FY 2027
- China Volume-Based Procurement (VBP) and Market Weakness
- Tariff Headwinds and Reimbursement RecoveriesTrigger: Tariff impact exceeding the 120-130 basis point headwind on margins
Research as of 19 Jun 2026